1. Residual radiological opacities correlate with disease outcomes in ICU-treated COVID-19
- Author
-
Mikael Björnson, Ann Mari Svensson, Cecilia He, Magnus Sköld, Sven Nyrén, Malin Nygren-Bonnier, Judith Bruchfeld, Michael Runold, Francesca Campoccia Jalde, and Anna Kistner
- Subjects
COVID-19 ,computed tomography ,spirometry ,exercise test ,pulmonary diffusing capacity ,residual radiological opacities ,Medicine (General) ,R5-920 - Abstract
BackgroundFew studies consider both radiological and functional outcomes in COVID-19 survivors treated in the intensive care unit (ICU). We investigated clinical findings and pulmonary abnormalities on chest computed tomography (CT) and compared outcomes of severe versus mild-moderate acute respiratory distress syndrome (ARDS) on long-term follow-up.MethodsThis longitudinal cohort study included 118 COVID-19 patients (median age, 58 years; 79% men). Thoracic CT scans were performed 4, 10, and 22 months after hospital discharge. Two independent blinded radiologists analyzed the 10 months scans and scored the radiology findings semi-quantitatively, as no/minor versus widespread opacities [low-radiology opacity grade (ROG) versus high-ROG]. ARDS severity was based on the PaO2/FiO2 ratio. The 6 min walk test (6MWT) was performed after 3 and 9 months, and lung diffusion capacity for carbon monoxide (DLCO) and lung volume measurement after 9 and 15 months. Dynamic spirometry was done at all time points. Residual symptoms and health-related quality-of-life (HRQL) were evaluated using validated questionnaires.ResultsAt 10 months, most patients (81/118; 69%) were classified as high-ROG, of which 70% had severe ARDS during hospitalisation; 69% of those with mild-moderate ARDS also had high-ROG. Patients with high-ROG had longer ICU stay and lower PaO2/FiO2 during hospitalisation (p 25%) in most patients at follow-up at 10 months (AUC 0.74).ConclusionResidual radiological abnormalities in ICU-treated COVID-19 patients, evaluated for up to 2 years, relate to persisting symptoms and impaired lung function, demanding careful follow-up regardless of ARDS severity at hospitalisation.
- Published
- 2024
- Full Text
- View/download PDF